Again, not being approved for 2 years, for whatever reason, doesn't match the original claim of not being approved at all because it's too expensive.

If you’re a parent of a child suffering from a terrible genetic condition with what is effectively a miracle cure available, does it really matter to you if perhaps, hypothetically, someday—years later—a drug your government already deems safe is made available to you?

Prices aren’t static. Competitors enter the market. Governments are willing to offer more or less. Eventually, generics or biosimilars become available.

It’s 100% accurate that English and Canadian citizens were denied access to these new drugs until they ceased being “too expensive” (at which point they were no longer “new”).